Remagine Labs
PrivateLast Round
Pre Seed
Aug 4, 2025
Total Funding Raised
$3.16M
Company Overview
Remagine Labs is a therapeutic devices company developing a wearable, electronically controlled drug delivery system for chronic conditions like epilepsy.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Precision Medicine, Biotechnology, Health IoT
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Remagine Labs Comparables
Compare Remagine Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ategenos Pharmaceuticals | 83% | |
| Biotts | 72% | |
| Nemaura Pharma | 71% |
Remagine Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Aug 4, 2025 | ||||
| Grant | Mar 8, 2024 |
Remagine Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Monash University | Pre Seed |
| Australian Government Department of Industry, Science and Resources | Grant |
| Breakthrough Victoria | Pre Seed |
| Tin Alley Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
Monthly visitors increased 235% to 937.
- Dec 8, 2025
Monthly visitors grew 48% MoM.
Recent news
Latest coverage and updates
- is_developingJul 7, 2026
Remagine Labs, Inc. is developing iontophoretic transdermal patch for the delivery of ulixacaltamide on Jul 7th '26.
Remagine Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Remagine Labs's valuation, stock price, and market status.
Is Remagine Labs a public or private company?
Remagine Labs is a private company.
What is the current stock price of Remagine Labs?
Remagine Labs is a private company with no public stock price. No recent secondary market data is available.
How much is Remagine Labs worth (valuation)?
Valuation information for Remagine Labs is not publicly available.
Can I buy Remagine Labs stock?
Remagine Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Remagine Labs's last funding round?
Remagine Labs's most recent funding round was Pre Seed on August 4, 2025.
Who are the main investors in Remagine Labs?
Key investors in Remagine Labs include Monash University, Australian Government Department of Industry, Science and Resources, Breakthrough Victoria, Tin Alley Ventures.
Will Remagine Labs IPO soon?
No public IPO plans have been announced for Remagine Labs.
How can I track Remagine Labs secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Remagine Labs's secondary market activity and sign up for updates.